Biotech company that discovers, develops, manufactures and delivers human theraputics
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | FORBES-TATE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | FORBES-TATE |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2024 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2024 | FORBES-TATE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | FORBES-TATE |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2023 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FORBES-TATE | 52 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 51 |
| Taxation/Internal Revenue Code | 47 |
| Medical/Disease Research/Clinical Labs | 34 |
| Budget/Appropriations | 25 |